Bruce Cozadd, Co-Founder, Chairperson and CEO, Plans to Retire as CEO Upon Appointment of Successor by the End of 2025; Will Continue as Chair of the Board Mr. Cozadd Has Led Growth of Company from Founding to $4 Billion+ in 2024 Expected Total Revenue Board Will Lead Comprehensive...
Read More Details
Finally We wish PressBee provided you with enough information of ( Jazz Pharmaceuticals Announces CEO Succession Plan )
Also on site :